M3, Inc. (MTHRF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 24.61 means the share price is 24.61 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $6.92B is the value of all shares combined. Beta 0.47: the stock has moved about 53% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerM3, Inc. (MTHRF) trades at $10.36 with MoonshotScore 48/100 (Grade C). M3, Inc. is a leading Japanese healthcare information services provider, focusing on internet-based solutions for medical professionals. Market cap: $6.92B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for MTHRF: MTHRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MTHRF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MTHRF: 2/3 scored disciplines lean bullish. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
M3, Inc. (MTHRF) Healthcare & Pipeline Overview
M3, Inc. stands out in the healthcare information services sector by providing a comprehensive suite of internet-based solutions for medical professionals, including platforms for career development, medical information, and pharmaceutical marketing.
What Is the Investment Thesis for MTHRF?
M3, Inc. has demonstrated a robust financial performance with a market capitalization of $6.92B and a profit margin of 14.0%, supported by a gross margin of 50.0%. The company's diverse revenue streams from its digital platforms and services present significant growth potential, particularly in the expanding healthcare information services market. With ongoing investments in technology and international expansion, M3 is well-positioned to capture a larger share of the market. The company's P/E ratio of 24.61 indicates a healthy valuation relative to its earnings, suggesting that M3 is effectively leveraging its resources for growth. Key growth catalysts include the increasing demand for digital healthcare solutions, the expansion of its international presence, and the continuous enhancement of its service offerings. However, potential risks such as regulatory changes and competition from established players in the healthcare sector must be monitored closely.
Based on FMP financials and quantitative analysis
MTHRF Key Highlights
Market Cap of $6.92B reflects strong market positioning in healthcare information services.
- Profit Margin of 14.0% indicates effective cost management and operational efficiency.
- Gross Margin of 50.0% exceeds industry averages, showcasing robust service profitability.
- P/E Ratio of 24.61 suggests a reasonable valuation given the company's growth prospects.
- Beta of 0.47 indicates lower volatility compared to the broader market.
Who Are MTHRF's Competitors?
MTHRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| RCDTF Recordati Industria Chimica e Farmaceutica S.p.A. | $58.00 | 0.00% | $11.9B | — |
| BDUUF Bangkok Dusit Medical Services Public Company Limited | $0.64 | 0.00% | $10.2B | — |
| SHPMF Shanghai Pharmaceuticals Holding Co., Ltd | $1.46 | 0.00% | $8.46B | — |
| WILLF Demant A/S | $45.55 | +3.45% | $9.61B | — |
| GIFLF Grifols, S.A. | $11.33 | +2.26% | $7.71B | 529-signal |
| HNGE Hinge Health, Inc. | $90.02 | +1.99% | $6.97B | 905-pillar |
| HQY HealthEquity, Inc. | $95.70 | +1.22% | $8.00B | 905-pillar |
| TXG 10x Genomics, Inc. | $68.59 | +3.33% | $8.71B | 395-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are MTHRF's Key Strengths?
Diverse portfolio of digital platforms tailored for healthcare professionals.
- Strong market presence in Japan with expansion into international markets.
- High gross margin indicating effective cost management.
- Established relationships with healthcare professionals and pharmaceutical companies.
What Are MTHRF's Weaknesses?
Dependency on the Japanese market for a significant portion of revenue.
- Limited brand recognition outside of Asia compared to global competitors.
- Potential regulatory challenges in international markets.
- High competition in the digital healthcare space.
What Are the Growth Opportunities for MTHRF?
- Expansion of Digital Platforms: M3, Inc. is poised to enhance its digital platform offerings, particularly m3.com and AskDoctors, aiming to increase user engagement and subscription rates. The global telemedicine market is expected to grow from $45 billion in 2020 to $175 billion by 2026, providing a substantial opportunity for M3 to capture a larger audience and increase revenue streams.
- International Market Penetration: M3's international services, such as MDLinx and Doctorsnetuk, present significant growth potential. As healthcare systems worldwide increasingly adopt digital solutions, M3 aims to expand its footprint in major markets like the U.S. and Europe, targeting a market size of over $100 billion by 2025 in healthcare IT.
- Career Solutions for Healthcare Professionals: The m3com CAREER service is designed to support the career development of doctors and pharmacists. With the healthcare workforce continuously evolving, M3 can capitalize on the growing demand for career support services, projected to grow at a CAGR of 10% through 2025.
- Pharmaceutical Marketing Services: M3's engagement in sales and marketing for pharmaceuticals and medical devices positions it to benefit from the increasing demand for innovative marketing solutions in the healthcare sector.
- Electronic Medical Records Development: M3's involvement in the development and maintenance of electronic medical records aligns with the industry's shift towards digitalization.
What Threats Does MTHRF Face?
- Intense competition from established healthcare information service providers.
- Rapid technological changes requiring continuous innovation.
- Regulatory changes impacting operations in different countries.
- Economic downturns affecting healthcare spending.
What Are MTHRF's Competitive Advantages?
- Established brand recognition in the Japanese healthcare market.
- Comprehensive suite of digital platforms catering to various healthcare needs.
- Strong relationships with healthcare professionals and pharmaceutical companies.
- Expertise in navigating regulatory environments in multiple countries.
- Diverse revenue streams reducing dependency on any single service.
What Does MTHRF Do?
M3, Inc. was founded in 2000 and is headquartered in Tokyo, Japan. Initially incorporated as So-netM3, Inc., the company rebranded to M3, Inc. in January 2010. M3 primarily focuses on delivering internet-based services to physicians and healthcare professionals through a diverse range of digital platforms. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. The flagship platform, m3.com, serves as an exclusive online portal providing healthcare information to its members. MR-kun allows doctors to access continuous updates and content from the m3com system, while QOL-kun offers non-medical life-enhancement information. For public inquiries, M3 operates AskDoctors, where registered medical experts address health-related questions. Internationally, M3 extends its services through MDLinx for U.S. medical professionals and Doctorsnetuk in the U.K., supporting pharmaceutical companies and providing drug information databases across Europe. Additionally, M3 supports career development for healthcare professionals through its m3com CAREER service. Beyond these platforms, M3 engages in various activities within the medical and pharmaceutical sectors, including sales and marketing for pharmaceuticals and medical devices, development of electronic medical records, and management consulting for medical facilities. This multifaceted approach positions M3 as a key player in the healthcare information services industry, catering to both healthcare professionals and the pharmaceutical sector.
What Products and Services Does MTHRF Offer?
- Provide internet-based services tailored for healthcare professionals.
- Operate m3.com, a members-only portal for healthcare information.
- Facilitate career development for doctors and pharmacists through m3com CAREER.
- Conduct surveys and provide consulting services for medical facilities.
- Engage in sales and marketing for pharmaceuticals and medical devices.
- Manage clinical trial facilities and home-visit nursing services.
How Does MTHRF Make Money?
- Generate revenue through subscription services for healthcare professionals.
- Offer marketing and consulting services to pharmaceutical companies.
- Provide career development resources for medical professionals.
- Engage in the development and maintenance of electronic medical records.
- Conduct surveys and research services for healthcare institutions.
What Industry Does MTHRF Operate In?
The healthcare information services industry is experiencing significant growth, driven by the increasing reliance on digital solutions for healthcare delivery. M3, Inc. is strategically positioned within this expanding market, leveraging its comprehensive digital platforms to cater to healthcare professionals and pharmaceutical companies. The competitive landscape includes notable players such as Recordati Industria Chimica e Farmaceutica S.p.A. and Shanghai Pharmaceuticals Holding Co., Ltd., highlighting the need for continuous innovation and service enhancement.
Who Are MTHRF's Key Customers?
- Healthcare professionals including doctors and pharmacists.
- Pharmaceutical companies seeking marketing and consulting services.
- Medical institutions requiring electronic medical records and consulting.
- General public seeking health information through AskDoctors.
- International medical professionals using MDLinx and Doctorsnetuk.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in JPY, converted to USD
Why 48?
This rating comes from our nine-signal model, which produces a score but not a per-factor breakdown. The sector-relative five-pillar model, which explains its own contributions, does not cover this listing yet. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 48 |
| 2026-08-26 | 48 |
| 2026-08-29 | 48 |
| 2026-09-01 | 48 |
| 2026-09-04 | 48 |
| 2026-09-07 | 48 |
| 2026-09-10 | 48 |
What changed?
The score has stayed at 48.
Over the same 18 days the stock moved +0.0%.
M3, Inc. (MTHRF) Valuation Context
Valued at $6.92B, MTHRF is classified as a mid-cap stock. Relative to its peer group, MTHRF's quantitative score of 48/100 is below the peer average of 68/100.
MTHRF Revenue & Earnings Trend
In Q1 FY2027, MTHRF generated $582.1M in top-line revenue, marking a sequential increase of 2.2%. The company recorded net income of $58.6M, with diluted EPS of $0.09. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, MTHRF averaged $0.11 in diluted EPS.
Company Profile
M3, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Tokyo, JP. The company is led by CEO Itaru Tanimura. MTHRF has traded publicly since 2014.
Key Financial Metrics
Return on equity for M3, Inc. stands at 12.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.7%, showing how much profit it generates from its asset base. MTHRF trades at a trailing price-to-earnings ratio of 24.61, above the Healthcare sector average of ~21.50x. A current ratio of 2.73 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.1%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
M3, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.37 places it in the safe zone, indicating low near-term bankruptcy risk.
Earnings Track Record
M3, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 7.3% below estimates on average.
MTHRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Diverse portfolio of digital platforms tailored for healthcare professionals.
- Strong market presence in Japan with expansion into international markets.
- High gross margin indicating effective cost management.
- Established relationships with healthcare professionals and pharmaceutical companies.
Bear Case
- Dependency on the Japanese market for a significant portion of revenue.
- Limited brand recognition outside of Asia compared to global competitors.
- Potential regulatory challenges in international markets.
- High competition in the digital healthcare space.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2027 | $582M | $59M | $0.09 |
| Q4 FY2026 | $569M | $49M | $0.07 |
| Q3 FY2026 | $609M | $123M | $0.18 |
| Q2 FY2026 | $559M | $72M | $0.11 |
Q1 FY2027 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from JPY at today's rate
MTHRF Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Oct 1, 2019
-
Stocks That Hit 52-Week Highs On Monday
· Sep 30, 2019
MTHRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MTHRF.
Price Targets
Wall Street price target analysis for MTHRF.
MTHRF MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. MTHRF scores 48/100 (Grade C): the number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
MTHRF OTC Market Information
MTHRF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
M3, Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for MTHRF?
MTHRF holds an AI Score of 48/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. The number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed. M3, Inc. is a leading Japanese healthcare information services provider, focusing on internet-based solutions for medical professionals.
Is MTHRF a good stock?
Stock Expert AI does not rate MTHRF buy, sell or hold. M3, Inc. carries a MoonshotScore of 48/100 on the legacy nine-factor engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the key factors to evaluate for MTHRF?
M3, Inc. (MTHRF) holds a MoonshotScore of 48/100 (low). P/E: 24.61x vs the S&P 500's ~20-25x. M3, Inc. has demonstrated a robust financial performance with a market capitalization of $6.92B and a profit margin of 14.0%, supported by a gross margin of 50.0%. Not financial advice.
How frequently does MTHRF data refresh on this page?
MTHRF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MTHRF's recent stock price performance?
M3, Inc. (MTHRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio of digital platforms tailored for healthcare professionals. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MTHRF overvalued or undervalued right now?
M3, Inc. (MTHRF) trades at 24.61x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of MTHRF?
Yes, most major brokerages offer fractional shares of M3, Inc. (MTHRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MTHRF's earnings and financial reports?
M3, Inc. (MTHRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for MTHRF earnings announcements.
What should investors new to MTHRF understand first?
M3, Inc. (MTHRF) operates in Medical - Healthcare Information Services (Healthcare) and is worth researching across volatility, fundamentals, and industry context. Its current MoonshotScore is 48/100. With a market cap of $6.92B, it is a larger company which tends to be less volatile. The P/E ratio is 24.61x. A notable strength: Diverse portfolio of digital platforms tailored for healthcare professionals.. Start with the Company Overview and MoonshotScore tabs for a structured introduction.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.